Description
Tirzepatide pairs GIP and GLP-1 activity in one molecule — the dual agonist that reset metabolic research. Studied for glucose control, appetite signalling and body-weight endpoints. Lyophilized powder, 3 mL vial. For research use only.
● Member rewards
Members save up to 30%.
Create a free account — discounts apply automatically at checkout.
10%
Create an account
+10%
3 or more units
20%
Orders over $1,000
10% ea
Refer a friend — both save
Tirzepatide 20 mg (SVELTE)
$140.00
Dual GIP / GLP-1 Agonist · 20 mg vial · ≥ 99% HPLC
Certificate of Analysis.
PASS · 99.85%Identity (LC-MS)Tirzepatide — Confirmed (LC-MS)
Purity (HPLC-UV)99.85%
Net peptide12.19 mg
AppearanceWhite lyophilized powder
Tested byFreedom Diagnostics
Lot2606150437
Reported17 JUN 2026
Reviews
There are no reviews yet.